PSP Research »

Exelixis shares owned by PSP Research

Quarter-by-quarter ownership of Exelixis (EXEL) shares owned by PSP Research from 13F filings

Historical chart of PSP Research investment in Exelixis

Tip: Access up to 7 years of quarterly data

All positions including Exelixis held by PSP Research consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Exelixis by PSP Research

Quarter filed Position value Share count Share price at filing
2025-12-31 $524k 12k 43.83

More positions owned by PSP Research

Ishares Tr 0-3 Mnth Treasry (SGOV)
Praxis Precision Medicines I Com New (PRAX)
Travere Therapeutics (TVTX)
Tyra Biosciences (TYRA)
Pharvaris N V (PHVS)
Jazz Pharmaceuticals Shs Usd (JAZZ)
Celldex Therapeutics Com New (CLDX)
Cg Oncology (CGON)
Belite Bio Sponsored Ads (BLTE)
Ascendis Pharma A/s Sponsored Adr (ASND)
Apellis Pharmaceuticals (APLS)
Terns Pharmaceuticals (TERN)
Revolution Medicines (RVMD)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Bridgebio Pharma (BBIO)

View all positions for PSP Research

Top funds holding Exelixis

BlackRock
Vanguard Group
Farallon Capital Management
Renaissance Technologies
AQR Capital Management
State Street Corporation
Hanna Zanoni
LSV Asset Management
Geode Capital Management
Invesco
Arrowstreet Capital, Limited Partnership
Dimensional Fund Advisors
UBS Group
Assetmark
Caisse de depot et placement du Quebec

View all funds holding Exelixis